Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasishta S Tatapudi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Current Opinion in Nephrology and Hypertension|January 23, 2023
Physiologic considerations of pig-to-human kidney xenotransplantationVasishta S Tatapudi, Adam D Griesemer
Frontiers in Immunology|October 22, 2019
Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug LeadsVasishta S Tatapudi, Robert A Montgomery
Current Opinion in Nephrology and Hypertension|December 12, 2018
Differences in national and international guidelines regarding use of kidney stone formers as living kidney donorsVasishta S Tatapudi, David S Goldfarb
Current Transplantation Reports|December 8, 2017
Pharmacologic Complement Inhibition in Clinical TransplantationVasishta S Tatapudi, Robert A Montgomery
Nephron Extra|May 8, 2014
Symptomatic central venous stenosis in a hemodialysis patient leading to loss of arteriovenous access: a case report and literature reviewVasishta S Tatapudi, Noam Spinowitz, David S Goldfarb
Case Reports in Nephrology and Dialysis|March 30, 2018
Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic SyndromeVasishta S Tatapudi, Bonnie E Lonze, Ming Wu, et al.
Nature Reviews. Nephrology|July 10, 2018
HLA in transplantationRobert A Montgomery, Vasishta S Tatapudi, Mary S Leffell, et al.
Journal of the American Society of Nephrology : JASN|April 16, 2025
Xenotransplantation: Current Understanding of the Mechanism of Immune-Mediated InjuryVasishta S Tatapudi, Aprajita Mattoo, Tamar Schiff, et al.
Clinical Transplantation|June 24, 2021
Impact of the 2014 kidney allocation system changes on trends in A2/A2B into B kidney transplantation and organ procurement organization reporting of donor subtypingJeffrey Stern, Nasser Alnazari, Vasishta S Tatapudi, et al.
Annals of Transplantation|December 1, 2021
Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant RecipientsVasishta S Tatapudi, Dessislava Kopchaliiska, Gilberto J da Gente, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Current Opinion in Nephrology and Hypertension|January 23, 2023
Physiologic considerations of pig-to-human kidney xenotransplantationVasishta S Tatapudi, Adam D Griesemer
Frontiers in Immunology|October 22, 2019
Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug LeadsVasishta S Tatapudi, Robert A Montgomery
Current Opinion in Nephrology and Hypertension|December 12, 2018
Differences in national and international guidelines regarding use of kidney stone formers as living kidney donorsVasishta S Tatapudi, David S Goldfarb
Current Transplantation Reports|December 8, 2017
Pharmacologic Complement Inhibition in Clinical TransplantationVasishta S Tatapudi, Robert A Montgomery
Nephron Extra|May 8, 2014
Symptomatic central venous stenosis in a hemodialysis patient leading to loss of arteriovenous access: a case report and literature reviewVasishta S Tatapudi, Noam Spinowitz, David S Goldfarb
Case Reports in Nephrology and Dialysis|March 30, 2018
Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic SyndromeVasishta S Tatapudi, Bonnie E Lonze, Ming Wu, et al.
Nature Reviews. Nephrology|July 10, 2018
HLA in transplantationRobert A Montgomery, Vasishta S Tatapudi, Mary S Leffell, et al.
Journal of the American Society of Nephrology : JASN|April 16, 2025
Xenotransplantation: Current Understanding of the Mechanism of Immune-Mediated InjuryVasishta S Tatapudi, Aprajita Mattoo, Tamar Schiff, et al.
Clinical Transplantation|June 24, 2021
Impact of the 2014 kidney allocation system changes on trends in A2/A2B into B kidney transplantation and organ procurement organization reporting of donor subtypingJeffrey Stern, Nasser Alnazari, Vasishta S Tatapudi, et al.
Annals of Transplantation|December 1, 2021
Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant RecipientsVasishta S Tatapudi, Dessislava Kopchaliiska, Gilberto J da Gente, et al.
Pageof 3